Dataset Viewer
Text
stringlengths 7
11k
|
|---|
1,2-dipalmitoylphosphatidylcholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
1,2 dipalmitoylphosphatidylcholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
1,2-dihexadecyl-sn-glycerophosphocholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
1,2 dihexadecyl sn glycerophosphocholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
1,2-dipalmitoyl-glycerophosphocholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
1,2 dipalmitoyl glycerophosphocholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
dipalmitoylphosphatidylcholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
dipalmitoylglycerophosphocholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
dipalmitoyllecithin is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
3,5,9-trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxohexadecyl)oxy)-, inner salt, 4-oxide is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
dipalmitoyl phosphatidylcholine is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
phosphatidylcholine, dipalmitoyl is synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. it is also a major constituent of pulmonary surfactants.
|
1,4-alpha-glucan branching enzyme is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
1,4-alpha glucan branching enzyme is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
1,4 alpha glucan branching enzyme is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
branching enzyme, 1,4-alpha-glucan is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
enzyme, 1,4-alpha-glucan branching is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
branching enzyme is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
enzyme, branching is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
branching glycosyltransferase is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
glycosyltransferase, branching is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
starch branching enzyme is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
branching enzyme, starch is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
enzyme, starch branching is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
1,4-alpha-d-glucan:1,4-alpha-d-glucan 6-alpha-d-(1,4-alpha-d-glucano)-transferase is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
amylo-(1,4,6)-transglycosylase is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
alpha-glucan-branching glycosyltransferase is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
amylo (1-4 to 1-6)-transglucosidase is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
1,4-alpha-glucan branching enzyme (substance) is in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
|
1-carboxyglutamic acid is found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.
|
1 carboxyglutamic acid is found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.
|
gamma-carboxyglutamic acid is found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.
|
gamma carboxyglutamic acid is found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.
|
3-amino-1,1,3-propanetricarboxylic acid is found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.
|
1,1,3-propanetricarboxylic acid, 3-amino- is found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.
|
1-methyl-3-isobutylxanthine is a potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic amp and cyclic gmp in tissue and thereby activates cyclic nucleotide-regulated protein kinases
|
1 methyl 3 isobutylxanthine is a potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic amp and cyclic gmp in tissue and thereby activates cyclic nucleotide-regulated protein kinases
|
3-isobutyl-1-methylxanthine is a potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic amp and cyclic gmp in tissue and thereby activates cyclic nucleotide-regulated protein kinases
|
3 isobutyl 1 methylxanthine is a potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic amp and cyclic gmp in tissue and thereby activates cyclic nucleotide-regulated protein kinases
|
ibmx is a potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic amp and cyclic gmp in tissue and thereby activates cyclic nucleotide-regulated protein kinases
|
isobutyltheophylline is a potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic amp and cyclic gmp in tissue and thereby activates cyclic nucleotide-regulated protein kinases
|
1h-purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)- is a potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic amp and cyclic gmp in tissue and thereby activates cyclic nucleotide-regulated protein kinases
|
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease.
|
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes parkinsonlike symptoms.
|
mptp is a dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease.
|
mptp is 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes parkinsonlike symptoms.
|
n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease.
|
n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes parkinsonlike symptoms.
|
pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl- is a dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease.
|
pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl- is 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes parkinsonlike symptoms.
|
methylphenyltetrahydropyridine is a dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease.
|
methylphenyltetrahydropyridine is 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes parkinsonlike symptoms.
|
methylphenyltetrahydropyridine (substance) is a dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease.
|
methylphenyltetrahydropyridine (substance) is 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes parkinsonlike symptoms.
|
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp) is a dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease.
|
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp) is 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes parkinsonlike symptoms.
|
1-methyl-4-phenylpyridinium is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
1 methyl 4 phenylpyridinium is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
1-methyl-4-phenylpyridinium ion is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
1 methyl 4 phenylpyridinium ion is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
cyperquat is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
mpp+ is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
n-methyl-4-phenylpyridine is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
n methyl 4 phenylpyridine is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
1-methyl-4-phenylpyridine is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
1 methyl 4 phenylpyridine is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
n-methyl-4-phenylpyridinium is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
pyridinium, 1-methyl-4-phenyl- is an active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. the compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. these and other toxic effects lead to cessation of oxidative phosphorylation, atp depletion, and cell death. the compound, which is related to paraquat, has also been used as an herbicide.
|
1-naphthylamine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
1 naphthylamine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
alpha-naphthylamine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
alpha naphthylamine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
naphthalidine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
8-aminonaphthalene is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
8 aminonaphthalene is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
1-aminonaphthalene is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
1 aminonaphthalene is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
1-naphthalenamine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
1-naththylamine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
a- naphthylamine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
a-naphthylamine is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
1-naphthylamine (substance) is a suspected industrial carcinogen (and listed as such by osha). its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
|
1-naphthylisothiocyanate is a tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. it may cause skin and kidney damage.
|
1 naphthylisothiocyanate is a tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. it may cause skin and kidney damage.
|
alpha-naphthylisothiocyanate is a tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. it may cause skin and kidney damage.
|
alpha naphthylisothiocyanate is a tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. it may cause skin and kidney damage.
|
naphthalene, 1-isothiocyanato- is a tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. it may cause skin and kidney damage.
|
1-sarcosine-8-isoleucine angiotensin ii is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
1 sarcosine 8 isoleucine angiotensin ii is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
angiotensin ii, 1-sarcosine-8-isoleucine is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
1-sar-8-ile angiotensin ii is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
1 sar 8 ile angiotensin ii is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
angiotensin ii, 1-sar-8-ile is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
1-(n-methylglycine)-8-l-isoleucine-angiotensin ii is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
angiotensin ii, 1-(n-methylglycine)-8-l-isoleucine- is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
sarile is an angiotensin ii analog which acts as a highly specific inhibitor of angiotensin type 1 receptor.
|
11-hydroxycorticosteroids is a group of corticosteroids bearing a hydroxy group at the 11-position.
|
11 hydroxycorticosteroids is a group of corticosteroids bearing a hydroxy group at the 11-position.
|
16,16-dimethylprostaglandin e2 is a synthetic prostaglandin e analog that protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. the protective effect is independent of acid inhibition. it is also a potent inhibitor of pancreatic function and growth of experimental tumors.
|
16,16-dimethylprostaglandin e2 is a stable derivative of prostaglandin e2 (pge2) with potential hematopoietic activity. administration of 16,16 dimethyl-prostaglandin e2 (dmpge2) appears to lead to increased formation of hematopoietic stem and progenitor cells. even though the exact mechanism of action has yet to be fully elucidated, this agent may stimulate hematopoiesis by activating the wnt signaling pathway, which increases cellular levels of beta-catenin, a subunit of the cadherin protein complex.
|
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 8